|4Mar 31, 9:13 AM ET

Bacopoulos Nicholas G 4

4 · Cyclacel Pharmaceuticals, Inc. · Filed Mar 31, 2010

Insider Transaction Report

Form 4
Period: 2010-03-29
Transactions
  • Award

    Option

    2010-03-29+25,00025,000 total
    Exercise: $2.38Exp: 2020-03-29Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]These options are exercisable over a four-year period with one-fourth (1/4) of the options vesting on the first anniversary of the grant date and the balance vesting ratably on a monthly basis over the 36 months following thereafter.
  • [F2]The options were granted to Dr. Bacopoulos for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.

Documents

1 file
  • 4
    c98600_4x0.xmlPrimary

    MAIN DOCUMENT DESCRIPTION